文献速递颈动脉与弓上血管

3.0T MRA检测的易损斑块特征与颈动脉疾病症状性表现相关:系统综述与荟萃分析

Magnetic resonance angiography-detected vulnerable plaque features at 3.0 T field strength are associated with symptomatic presentation in carotid artery disease: A systematic review and meta-analysis.
PubMed 文献 · J Vasc Surg · 2025-11-12

结果显示VI型斑块(含斑块内出血、纤维帽破裂或表面血栓)与症状性表现强相关(未调整OR 5.03,95%CI 3.22-7.85),且可预测首发事件(HR 3.61,95%CI 2.32-5.62),而IV/V型斑块无判别性。

要点

  • 3.0T MRA-VWI检测的VI型斑块与症状性颈动脉疾病强相关(未调整OR 5.03)。
  • 斑块内出血(伴或不伴血栓)与症状相关(OR 5.31),且预测首发事件(HR 3.51)。
  • IV/V型斑块(脂质坏死核心)与症状无显著关联,不具判别性。

核心结论

  • 3.0T MRA-VWI检测的易损斑块与症状性状态一致相关,且无论场强如何,易损性均与首发同侧事件相关。
  • IV/V型(脂质坏死核心)单独不具判别性,将易损特征成像(尤其VI型斑块)纳入颈动脉狭窄常规评估可细化风险分层。

研究设计与样本

  • 系统综述与荟萃分析,遵循PRISMA指南并注册于PROSPERO,检索MEDLINE、Embase、CENTRAL、Web of Science、Epistemonikos及灰色文献至2024年7月。
  • 纳入标准为5例及以上成人患者接受3.0T MRA-VWI进行颈动脉斑块特征分析并报告卒中或短暂性脑缺血发作结局,排除复发性或血运重建后事件、动物研究及综述。

主要发现

  • 3.0T病例对照/横断面研究未调整荟萃分析中,VI型斑块(含斑块内出血、纤维帽破裂或表面血栓)与症状强相关(合并OR 5.03,95%CI 3.22-7.85,I2=0%)。
  • 斑块内出血伴或不伴血栓与症状相关(OR 5.31,95%CI 3.10-9.11,I2=8%),单纯斑块内出血亦相关(OR 4.88,95%CI 1.90-12.50,I2=43.6%)。
  • 纤维帽破裂未调整时关联大但不显著(OR 4.59,95%CI 0.77-27.32,I2=15.2%),IV/V型斑块无关联(OR 0.50,95%CI 0.12-2.01,I2=6.6%)。
  • 调整后VI型(合并调整OR 3.56,95%CI 2.04-6.24,I2=0%)、斑块内出血伴或不伴血栓(OR 4.92,95%CI 1.56-15.53,I2=19.8%)及纤维帽破裂(OR 2.85,95%CI 2.28-3.56,I2=0%)关联仍显著;单纯斑块内出血强但不精确(OR 5.36,95%CI 0.56-51.46,I2=43.5%)。
  • 平行分析纳入三个1.5T队列和一个3.0T队列后,VI型(合并HR 3.61,95%CI 2.32-5.62,I2=0.4%)和斑块内出血(HR 3.51,95%CI 2.42-5.10,I2=0%)预测首发事件;脂质坏死核心不一致且总体不显著(HR 2.38,95%CI 0.15-38.76,I2=65.8%)。

关键数值与推荐

  • VI型斑块(含斑块内出血、纤维帽破裂或表面血栓)与症状性表现未调整合并OR 5.03(95%CI 3.22-7.85,I2=0%)。
  • VI型斑块调整后合并OR 3.56(95%CI 2.04-6.24,I2=0%)。
  • 斑块内出血伴或不伴血栓与症状未调整OR 5.31(95%CI 3.10-9.11,I2=8%)。
  • VI型斑块预测首发事件合并HR 3.61(95%CI 2.32-5.62,I2=0.4%),斑块内出血HR 3.51(95%CI 2.42-5.10,I2=0%)。
  • IV/V型斑块与症状无关联(OR 0.50,95%CI 0.12-2.01,I2=6.6%)。

临床怎么用

  • 在颈动脉狭窄评估中,可将3.0T MRA-VWI检测的易损斑块特征(尤其VI型斑块)纳入常规,以细化超出管腔狭窄的风险分层。
  • 识别斑块内出血、纤维帽破裂或表面血栓有助于识别症状性及首发事件高风险患者。
  • 脂质坏死核心单独不具判别性,不应仅凭此特征进行风险分层。

局限性

  • 纳入研究以病例对照/横断面为主,部分分析基于未调整数据,调整后部分关联不精确(如单纯斑块内出血OR 5.36,95%CI 0.56-51.46)。
  • 异质性在某些特征中较高(如脂质坏死核心I2=65.8%),可能影响合并效应可靠性。
  • 平行分析纳入1.5T与3.0T场强研究,场强差异可能对结果有影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the association between 3.0 T Magnetic resonance angiography with vessel wall imaging (MRA-VWI) detected vulnerable plaque features and the risk of symptomatic presentation and first-ever neurovascular events. METHODS: This study followed PRISMA guidelines and was registered in PROSPERO. We systematically searched MEDLINE, Embase, CENTRAL, Web of Science, Epistemonikos, and the gray literature up to July 2024. Eligible studies included five or more adult patients undergoing 3.0 T MRA-VWI for carotid plaque characterization with reporting outcomes of stroke or transient ischemic attack. Exclusion criteria were recurrent or post-revascularization events, animal studies, and reviews. Data were extracted from cross-sectional, case-control, and prospective cohort studies. Pooled odds ratios (OR) were recorded for symptomatic presentation, and hazard ratios (HR) for incident first-ever events. Random-effects models were applied, and heterogeneity was assessed using I2. A parallel analysis was performed for cohort studies to assess incident risk of asymptomatic patients including 1.5 T and 3.0 T strength fields. RESULTS: Thirteen studies met the inclusion criteria, of which 11 contributed to the quantitative analysis. In unadjusted meta-analyses of 3.0 T case-control/cross-sectional studies, type VI plaques (including intraplaque hemorrhage [IPH], ruptured cap, or surface thrombus) showed a strong association with symptoms (pooled OR, 5.03; 95% confidence interval [CI], 3.22-7.85; I2 = 0%), as did IPH with or without thrombus (OR, 5.31; 95% CI, 3.10-9.11; I2 = 8%) and IPH alone (OR, 4.88; 95% CI, 1.90-12.50; I2 = 43.6%). Ruptured fibrous cap showed a large but nonsignificant association unadjusted (OR, 4.59; 95% CI, 0.77-27.32; I2 = 15.2%), and type IV/V plaques showed no association (OR, 0.50; 95% CI, 0.12-2.01; I2 = 6.6%). After adjustment, the associations remained and were significant for type VI (pooled adjusted OR, 3.56; 95% CI, 2.04-6.24; I2 = 0%), IPH with or without thrombus (OR, 4.92; 95% CI, 1.56-15.53; I2 = 19.8%), and ruptured cap (OR, 2.85; 95% CI, 2.28-3.56; I2 = 0%); IPH alone remained strong but imprecise (OR, 5.36; 95% CI, 0.56-51.46; I2 = 43.5%). In the parallel analysis, results remained consistent after including three additional cohorts of 1.5 T with one of 3.0 T, as type VI (pooled HR, 3.61; 95% CI, 2.32-5.62; I2 = 0.4%) and IPH (HR, 3.51; 95% CI, 2.42-5.10; I2 = 0%) predicted first-ever events in both 1.5 T and 3.0 T strength fields. Lipid-rich necrotic core was inconsistent and overall nonsignificant with high heterogeneity (HR, 2.38; 95% CI, 0.15-38.76; I2 = 65.8%). CONCLUSIONS: We found the3.0 T MRA-VWI detection of vulnerable plaque was consistently associated with symptomatic status. Furthermore, despite field strength, vulnerability was associated with first-ever ipsilateral events. In contrast, type IV/V (lipid-rich necrotic core) alone was not discriminatory. Incorporation of vulnerable-feature imaging, particularly identification of type VI plaques into routine evaluation of carotid stenosis refines risk stratification beyond luminal narrowing alone.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Esquetini-Vernon C, Polania-Sandoval C, Meschia JF, et al. Magnetic resonance angiography-detected vulnerable plaque features at 3.0 T field strength are associated with symptomatic presentation in carotid artery disease: A systematic review and meta-analysis. J Vasc Surg. 2025. PMID: 41232817. doi:10.1016/j.jvs.2025.11.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。